Imgatuzumab Recombinant Monoclonal Antibody for SPR, Flow, ELISA, Functional Imgatuzumab is under investigation in clinical trial NCT01326000 (A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line
Imgatuzumab Recombinant Monoclonal Antibody for SPR, Flow, ELISA, Functional Imgatuzumab is under investigation in clinical trial NCT01326000 (A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line
Read more ...